EBITDA Margin ratio Analysis of aTyr Pharma Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY EBITDA Margin
Period Ending - Dec-23
Very Poor EBITDA Margin
-373.58
Period Ending - Dec-22
Very Poor EBITDA Margin
-429.16
Growth
12.95 %
Trailing Twelve Months EBITDA Margin
Period Ending - Dec-23
Very Poor EBITDA Margin
-1150.15
Most recent Quarter EBITDA Margin
Period Ending - Mar-24
Very Poor EBITDA Margin
-6751.49
EBITDA Margin Analysis of aTyr Pharma Inc
| Ebitda Margin Ratio of aTyr Pharma Inc with value of -1150.15 means that its operating expenses are Higher in relation to total revenue in trailing twelve months. |
| Ebitda Margin Ratio of aTyr Pharma Inc with value of -6751.49 means that its operating expenses are Higher in relation to total revenue in latest Quarter ending on Mar-24. |
| EBITDA Margin Ratio of LIFE has grown by 12.95 % Compared to previous Financial Year. |
| EBITDA Margin Ratio with value of -143.07 was highest in Year Dec-20 in last Five Years. |
| EBITDA Margin Ratio with value of -301962.61 was lowest in Year Dec-21 in last Five Years. |
| Latest EBITDA Margin Ratio with value of -373.58 is Greater than Average EBITDA Margin of -61635.57 in last five years. |
| Ebitda Margin of aTyr Pharma Inc is negative because of negative EBITDA in last Financial Year , last Quarter and also in last twelve Months |
Other EBITDA Margin Related Info of LIFE that may interest you.
aTyr Pharma Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| LIFE | 2.0 | 1.93 | 3.63 % | Biotechnology |
Defination of EBITDA Margin
EBITDA Margin is the profitability ratio that measures a company's earnings before interest, taxes, depreciation, and amortization as a percentage of revenue. EBITDA is the abbreviation for Earnings before Interest, Taxes, Depreciation, and Amortization. more ..
EBITDA Margin Related Ratios
| NetProfitMargin | ReturnOnEquity |
Tsr Profitability Index
| Poor Profitability Stock | |
FY - Historical EBITDA Margin of aTyr Pharma Inc
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
|---|---|---|---|---|---|---|---|
| EBITDA Margin | -373.58 | -429.16 | -301962.61 | -143.07 | -5269.43 | 0 | 0 |
| Change | 12.95 % | 99.86 % | -210958.90 % | 97.28 % |
FY Chart of EBITDA Margin of aTyr Pharma Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)